Annual ROA
0.56%
+6.45%+109.51%
30 April 2024
Summary:
PharmaCyte Biotech annual return on assets is currently 0.56%, with the most recent change of +6.45% (+109.51%) on 30 April 2024. During the last 3 years, it has risen by +48.52% (+101.17%). PMCB annual ROA is now at all-time high.PMCB ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROA
38.44%
+37.98%+8256.52%
31 July 2024
Summary:
PharmaCyte Biotech quarterly return on assets is currently 38.44%, with the most recent change of +37.98% (+8256.52%) on 31 July 2024. Over the past year, it has increased by +40.10% (+2415.66%). PMCB quarterly ROA is now at all-time high.PMCB Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PMCB ROA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +109.5% | +2415.7% |
| 3 y3 years | +101.2% | +395.9% |
| 5 y5 years | +100.8% | +154.0% |
PMCB ROA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +101.2% | at high | +395.9% |
| 5 y | 5 years | at high | +100.8% | at high | +150.3% |
| alltime | all time | at high | +100.0% | at high | +102.6% |
PharmaCyte Biotech ROA History
| Date | Annual | Quarterly |
|---|---|---|
| July 2024 | - | 38.44%(+8256.5%) |
| Apr 2024 | 0.56%(-109.5%) | 0.46%(-130.7%) |
| Jan 2024 | - | -1.50%(-9.6%) |
| Oct 2023 | - | -1.66%(-78.2%) |
| July 2023 | - | -7.60%(+41.3%) |
| Apr 2023 | -5.89%(+25.9%) | -5.38%(-19.0%) |
| Jan 2023 | - | -6.64%(+3.3%) |
| Oct 2022 | - | -6.43%(+22.5%) |
| July 2022 | - | -5.25%(-12.8%) |
| Apr 2022 | -4.68%(-90.2%) | -6.02%(-21.0%) |
| Jan 2022 | - | -7.62%(-41.3%) |
| Oct 2021 | - | -12.99%(-72.5%) |
| July 2021 | - | -47.27%(+6.6%) |
| Apr 2021 | -47.96%(-22.7%) | -44.34%(+2.2%) |
| Jan 2021 | - | -43.39%(-12.6%) |
| Oct 2020 | - | -49.64%(-15.8%) |
| July 2020 | - | -58.94%(-13.6%) |
| Apr 2020 | -62.06%(-11.8%) | -68.19%(-10.8%) |
| Jan 2020 | - | -76.42%(+7.3%) |
| Oct 2019 | - | -71.20%(+4.0%) |
| July 2019 | - | -68.45%(+4.2%) |
| Apr 2019 | -70.34%(-33.9%) | -65.69%(-1.2%) |
| Jan 2019 | - | -66.52%(-21.6%) |
| Oct 2018 | - | -84.89%(-6.1%) |
| July 2018 | - | -90.36%(+1.2%) |
| Apr 2018 | -106.49%(+107.7%) | -89.33%(+9.6%) |
| Jan 2018 | - | -81.48%(+15.7%) |
| Oct 2017 | - | -70.45%(+12.4%) |
| July 2017 | - | -62.70%(+7.7%) |
| Apr 2017 | -51.27%(-39.5%) | -58.21%(-4.2%) |
| Jan 2017 | - | -60.77%(-9.2%) |
| Oct 2016 | - | -66.90%(-9.1%) |
| July 2016 | - | -73.61%(-6.1%) |
| Apr 2016 | -84.69%(-20.7%) | -78.38%(-16.5%) |
| Jan 2016 | - | -93.86%(+0.1%) |
| Oct 2015 | - | -93.73%(-27.0%) |
| July 2015 | - | -128.34%(-0.5%) |
| Apr 2015 | -106.78%(-63.5%) | -129.01%(-57.9%) |
| Jan 2015 | - | -306.20%(+1.2%) |
| Oct 2014 | - | -302.70%(-13.1%) |
| July 2014 | - | -348.17%(-26.7%) |
| Apr 2014 | -292.55% | -474.67%(+76.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jan 2014 | - | -268.89%(-18.8%) |
| Oct 2013 | - | -331.28%(+58.9%) |
| July 2013 | - | -208.49%(+222.3%) |
| Apr 2013 | -64.38%(-43.6%) | -64.68%(-17.2%) |
| Jan 2013 | - | -78.10%(-4.3%) |
| Oct 2012 | - | -81.62%(-10.2%) |
| July 2012 | - | -90.85%(-18.8%) |
| Apr 2012 | -114.15%(-0.3%) | -111.82%(-31.7%) |
| Jan 2012 | - | -163.79%(-3.3%) |
| Oct 2011 | - | -169.34%(+10.7%) |
| July 2011 | - | -153.04%(+31.3%) |
| Apr 2011 | -114.45%(-30.8%) | -116.56%(-28.3%) |
| Jan 2011 | - | -162.51%(-5.5%) |
| Oct 2010 | - | -171.91%(+22.7%) |
| July 2010 | - | -140.10%(+11.2%) |
| Apr 2010 | -165.48%(+60.4%) | -126.03%(-16.2%) |
| Jan 2010 | - | -150.39%(+21.7%) |
| Oct 2009 | - | -123.58%(+4.9%) |
| July 2009 | - | -117.85%(+10.0%) |
| Apr 2009 | -103.15%(+63.5%) | -107.16%(+132.7%) |
| Jan 2009 | - | -46.05%(-10.2%) |
| Oct 2008 | - | -51.28%(-21.0%) |
| July 2008 | - | -64.95%(-19.4%) |
| Apr 2008 | -63.09%(-16.7%) | -80.60%(-2.9%) |
| Jan 2008 | - | -82.97%(+5.0%) |
| Oct 2007 | - | -79.01%(+15.6%) |
| July 2007 | - | -68.33%(-12.1%) |
| Apr 2007 | -75.77%(-77.9%) | -77.76%(-63.8%) |
| Jan 2007 | - | -214.69%(-24.1%) |
| Oct 2006 | - | -282.95%(-38.2%) |
| July 2006 | - | -458.18%(-36.1%) |
| Apr 2006 | -343.03%(-79.5%) | -717.03%(-51.9%) |
| Jan 2006 | - | -1489.28%(+57.0%) |
| Oct 2005 | - | -948.73%(+108.4%) |
| July 2005 | - | -455.22%(+34.5%) |
| Apr 2005 | -1670.44%(+69.1%) | -338.52%(+12.4%) |
| Jan 2005 | - | -301.17%(+7.4%) |
| Oct 2004 | - | -280.50%(+35.5%) |
| July 2004 | - | -206.97%(-54.4%) |
| Apr 2004 | -988.05% | -453.97%(+2231.6%) |
| Jan 2004 | - | -19.47%(-25.0%) |
| Oct 2003 | - | -25.97% |
FAQ
- What is PharmaCyte Biotech annual return on assets?
- What is the all time high annual ROA for PharmaCyte Biotech?
- What is PharmaCyte Biotech annual ROA year-on-year change?
- What is PharmaCyte Biotech quarterly return on assets?
- What is the all time high quarterly ROA for PharmaCyte Biotech?
- What is PharmaCyte Biotech quarterly ROA year-on-year change?
What is PharmaCyte Biotech annual return on assets?
The current annual ROA of PMCB is 0.56%
What is the all time high annual ROA for PharmaCyte Biotech?
PharmaCyte Biotech all-time high annual return on assets is 0.56%
What is PharmaCyte Biotech annual ROA year-on-year change?
Over the past year, PMCB annual return on assets has changed by +6.45% (+109.51%)
What is PharmaCyte Biotech quarterly return on assets?
The current quarterly ROA of PMCB is 38.44%
What is the all time high quarterly ROA for PharmaCyte Biotech?
PharmaCyte Biotech all-time high quarterly return on assets is 38.44%
What is PharmaCyte Biotech quarterly ROA year-on-year change?
Over the past year, PMCB quarterly return on assets has changed by +40.10% (+2415.66%)